Moral Hazard and the Pharmaceutical Benefits Scheme. The extent and significance of moral hazard in the PBS is an issue of significance for all Australians. Pharmaceuticals are a central feature in maintaining the health of Australians and with factors such as an ageing population and technological advances the centrality of pharmaceuticals is likely to be consolidated One, if not the, major challenge will be how to provide pharmaceuticals efficiently, equitably and sustainably. If significant a ....Moral Hazard and the Pharmaceutical Benefits Scheme. The extent and significance of moral hazard in the PBS is an issue of significance for all Australians. Pharmaceuticals are a central feature in maintaining the health of Australians and with factors such as an ageing population and technological advances the centrality of pharmaceuticals is likely to be consolidated One, if not the, major challenge will be how to provide pharmaceuticals efficiently, equitably and sustainably. If significant and extensive, moral hazard potentially compromises PBS efficiency and threatens sustainability. The proposed project represents a significant empirical contribution to understanding the impact of moral hazard on the PBS and will make a significant contribution towards making the PBS sustainableRead moreRead less
Chronic Disease Prevention and Treatment - Cost-Benefit Model Systems to Assist with Priority Setting. The key benefit of the proposal to develop linked chronic disease models that are able to account for comorbidities will be that a much more accurate picture of the health and financial implications of chronic diseases will be obtainable than with the traditional 'disease-by-disease' based studies. Such a global approach is particularly relevant to analysis of chronic disease prevention and/or ....Chronic Disease Prevention and Treatment - Cost-Benefit Model Systems to Assist with Priority Setting. The key benefit of the proposal to develop linked chronic disease models that are able to account for comorbidities will be that a much more accurate picture of the health and financial implications of chronic diseases will be obtainable than with the traditional 'disease-by-disease' based studies. Such a global approach is particularly relevant to analysis of chronic disease prevention and/or treatment, because the lifestyle related risk factors are common to many such diseases. Overall, the linked models will be able to improve on current decision making processes, providing a more complete view of chronic disease costs and benefits - either today, or in future - under different prevention or treatment scenarios.Read moreRead less
Australian Laureate Fellowships - Grant ID: FL110100247
Funder
Australian Research Council
Funding Amount
$2,461,000.00
Summary
Understanding the implications of population ageing for the future costs of funding health care, aged care and aged pensions in Australia. Decisions about health insurance, aged care, superannuation and retirement are often very complex, and most people find making the best choices extremely challenging. This project will develop new models and design new policies that can help people make better decisions in these areas, leading to greater well being in retirement.
Reducing Indigenous incarceration using Justice Reinvestment: an exploratory case study. Utilising Justice Reinvestment methodology, this project explores the conditions, governance and cultural appropriateness of re-investing resources otherwise spent on incarceration, into services to enhance juvenile offenders’ ability to remain in their community to reduce further criminal behaviours and health costs associated with incarceration.
Post-implementation economic evaluation of childhood vaccination programs. This project will develop a novel framework for assessing the value for money achieved by childhood vaccination programs. This will provide decision makers with methodologically sound economic assessments that incorporate real world program outcomes.
Discovery Early Career Researcher Award - Grant ID: DE140100719
Funder
Australian Research Council
Funding Amount
$383,312.00
Summary
The health cost of extended delays for inpatient treatment. Extended delays for elective procedures in public hospitals impede the National Research Priority of promoting and maintaining good health. Using unique large survey data linked to multiple years of health administrative records and the death registry, this project provides comprehensive costs of waiting, capturing both in-hospital and out of hospital health deterioration and impacts on medical expenditure. The estimation strategy takes ....The health cost of extended delays for inpatient treatment. Extended delays for elective procedures in public hospitals impede the National Research Priority of promoting and maintaining good health. Using unique large survey data linked to multiple years of health administrative records and the death registry, this project provides comprehensive costs of waiting, capturing both in-hospital and out of hospital health deterioration and impacts on medical expenditure. The estimation strategy takes into account patients’ initial choice to join the waiting list instead of going to a private hospital and allows for variation in the costs of waiting across patients. The results will have significant policy implications for waiting time reduction policies, health resource prioritisation and promotion of health equity.Read moreRead less
Planning female and male vaccination and cervical screening strategies to achieve optimal prevention of HPV-related disease. The findings from this research will inform the development of public health policy on the most cost-effective utilisation of resources for preventing cervical, anogenital and head/neck cancers, and genital warts, in women and men, due to human papillomavirus (HPV). We will evaluate strategies for using emerging screening and vaccine technologies to prevent HPV-related dis ....Planning female and male vaccination and cervical screening strategies to achieve optimal prevention of HPV-related disease. The findings from this research will inform the development of public health policy on the most cost-effective utilisation of resources for preventing cervical, anogenital and head/neck cancers, and genital warts, in women and men, due to human papillomavirus (HPV). We will evaluate strategies for using emerging screening and vaccine technologies to prevent HPV-related disease, and assess potential adverse outcomes of vaccination. Men are currently not covered by routine vaccination or screening programs; this research will assess the benefit to men of vaccinating women only, and will consider the impact of vaccination and other interventions targeted towards men.Read moreRead less
Economic and Social Benefits of treating and preventing influenza in Aged Care Facilities. Influenza is a deadly issue for the elderly, their carers and the community. It reduces quality of life and productivity through hospitalisation and work absenteeism. By preventing influenza using an antiviral drug for residents and staff in aged care facilities there should be considerable economic and social benefits. This controlled scientific experiment will determine how much disease and death can be ....Economic and Social Benefits of treating and preventing influenza in Aged Care Facilities. Influenza is a deadly issue for the elderly, their carers and the community. It reduces quality of life and productivity through hospitalisation and work absenteeism. By preventing influenza using an antiviral drug for residents and staff in aged care facilities there should be considerable economic and social benefits. This controlled scientific experiment will determine how much disease and death can be averted and provide real data that is critical to planning for an influenza pandemic. It will direct where emphasis should be placed between the control measures of infection control (eg hand-washing, masks), vaccination and use of antiviral drugs. Annual outbreaks will be curtailed.Read moreRead less
Patient waiting times at public hospitals and the demand for private care. Public hospital waiting times compromise the objective of accessible health care for all Australians. Past policy focused on private insurance incentives to ease pressure on public hospitals. Current policy focuses on extra public provision. This will be the first Australian research to model the impact of waiting times on private health insurance and the choice between private and public hospital treatment. We will analy ....Patient waiting times at public hospitals and the demand for private care. Public hospital waiting times compromise the objective of accessible health care for all Australians. Past policy focused on private insurance incentives to ease pressure on public hospitals. Current policy focuses on extra public provision. This will be the first Australian research to model the impact of waiting times on private health insurance and the choice between private and public hospital treatment. We will analyse how waiting times differ by income, medical procedure and region, and quantify the benefits associated with different ways of reducing waiting lists. This research will provide an evidence base for effective policy design and lead to better targeting of health care investments.Read moreRead less
Climate Change and Burden of Disease: Current Risk and Future Burden. Climate change has had a negative impact on human health. However, few studies have assessed burden of diseases (BOD) for these climate-sensitive/heat attributable diseases. We will generate the first national picture of the climate attributable BOD in Australia, measured in Disability-Adjusted Life Year (DALY), the attribution from climate, and project future BOD under various climatic/demographic change scenarios. This proje ....Climate Change and Burden of Disease: Current Risk and Future Burden. Climate change has had a negative impact on human health. However, few studies have assessed burden of diseases (BOD) for these climate-sensitive/heat attributable diseases. We will generate the first national picture of the climate attributable BOD in Australia, measured in Disability-Adjusted Life Year (DALY), the attribution from climate, and project future BOD under various climatic/demographic change scenarios. This project will rank Australian climate-sensitive/heat attributable diseases by their current burden and projected increase under climate changes, and provide needed scientific evidence to policy-makers in the development, prioritization and implementation of current and future climate change and health adaptation strategies. Read moreRead less